Skip to main content Accessibility Statement

Investors

At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders


--

Minimum 15 minutes delayed. Source:

Upcoming Events


NOV 04 2024 5:00 PM EST

Q3 2024 Tactile Medical Earnings Conference Call

NOV 04 2024 5:00 PM EST

Recent News


  • Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024

    MINNEAPOLIS , Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2024 financial results will be

    Read more
  • Tactile Medical Launches Next-Generation Nimbl™ Lymphedema Platform

    Initial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema MINNEAPOLIS , Oct. 02, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic

    Read more
  • Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy

    Largest U.S. Prospective Clinical Trial Ever Conducted Demonstrated High Compliance with the Flexitouch® System and Significant Improvements Across Study Endpoints MINNEAPOLIS , Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a

    Read more